These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
552 related articles for article (PubMed ID: 18181049)
1. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population. Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049 [TBL] [Abstract][Full Text] [Related]
2. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study. Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493 [TBL] [Abstract][Full Text] [Related]
3. Androgen receptor polymorphisms and the incidence of prostate cancer. Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504 [TBL] [Abstract][Full Text] [Related]
4. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022 [TBL] [Abstract][Full Text] [Related]
6. The androgen receptor gene GGN microsatellite and prostate cancer risk. Platz EA; Giovannucci E; Dahl DM; Krithivas K; Hennekens CH; Brown M; Stampfer MJ; Kantoff PW Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):379-84. PubMed ID: 9610786 [TBL] [Abstract][Full Text] [Related]
7. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population? Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987 [TBL] [Abstract][Full Text] [Related]
8. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292 [TBL] [Abstract][Full Text] [Related]
9. Polymorphic repeats in the androgen receptor gene in high-risk sibships. Miller EA; Stanford JL; Hsu L; Noonan E; Ostrander EA Prostate; 2001 Aug; 48(3):200-5. PubMed ID: 11494335 [TBL] [Abstract][Full Text] [Related]
10. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905 [TBL] [Abstract][Full Text] [Related]
12. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors. Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468 [TBL] [Abstract][Full Text] [Related]
13. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Kadouri L; Easton DF; Edwards S; Hubert A; Kote-Jarai Z; Glaser B; Durocher F; Abeliovich D; Peretz T; Eeles RA Br J Cancer; 2001 Jul; 85(1):36-40. PubMed ID: 11437399 [TBL] [Abstract][Full Text] [Related]
14. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254 [TBL] [Abstract][Full Text] [Related]
15. GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients. Sasaki M; Karube A; Karube Y; Watari M; Sakuragi N; Fujimoto S; Dahiya R Biochem Biophys Res Commun; 2005 Apr; 329(1):100-4. PubMed ID: 15721279 [TBL] [Abstract][Full Text] [Related]
16. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer. Lange EM; Chen H; Brierley K; Livermore H; Wojno KJ; Langefeld CD; Lange K; Cooney KA Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):439-42. PubMed ID: 10794490 [TBL] [Abstract][Full Text] [Related]
17. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene. Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P Int J Mol Med; 2003 Apr; 11(4):529-33. PubMed ID: 12632109 [TBL] [Abstract][Full Text] [Related]
18. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Irvine RA; Yu MC; Ross RK; Coetzee GA Cancer Res; 1995 May; 55(9):1937-40. PubMed ID: 7728763 [TBL] [Abstract][Full Text] [Related]
19. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures. Langdahl BL; Stenkjaer L; Carstens M; Tofteng CL; Eriksen EF Calcif Tissue Int; 2003 Sep; 73(3):237-43. PubMed ID: 14667136 [TBL] [Abstract][Full Text] [Related]
20. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer. Binnie MC; Alexander FE; Heald C; Habib FK Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]